In surprise decision, US approves muscular dystrophy drug CNBCAmarin Stock, CRH, ServiceNow, StoneCo, Adobe And More Added To IBD Watchlists Investor's Business DailySarepta’s surprise FDA approval for rare disease drug excites investors MarketWatchFDA OKs Golodirsen (Vyondys 53) for Duchenne Muscular Dystrophy MedscapeStocks To Watch With Stock Market At Record Highs Include Paycom Software Investor's Business DailyView full coverage on Google News